Commentary

Page 11

Commentary

Efficacy of Varenicline for Smoking Cessation in Bipolar Disorder

July 25, 2014

Joseph F. Goldberg

Commentary

Update on Best Practices for Managing Bipolar Depression

May 15, 2014

Gary S. Sachs, Terence A. Ketter

Commentary

Schizophrenia: Mechanism of Action of Current and Novel Treatments

March 7, 2014

Christoph U. Correll, John M. Kane

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

February 19, 2014

Anissa Abi-Dargham, Jonathan M. Meyer

Commentary

Depression and Risk of Dementia: Exploring the Interface

December 15, 2013

Anton P. Porsteinsson, Inga M. Antonsdottir

Commentary

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

November 28, 2013

Larry Culpepper, Madhukar H. Trivedi

Commentary

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

October 15, 2013

Charles B. Nemeroff, Fred Seligman

Commentary

Preventing Domestic Violence in Families of Veterans

October 15, 2013

Commentary

Commentary: Psychiatric Pharmacist Integration Into the Medical Home

August 22, 2013

The use of multidisciplinary health care teams for patients with multiple complex needs may improve patient outcomes. In this Commentary, read about an often overlooked solution to care coordination...

Jerry R. McKee, Kelly C. Lee, Carla D. Cobb

Commentary

The Law of Diminishing Intent: Getting Excited About Apathy

August 15, 2013

Anton P. Porsteinsson, Michael J. Hasselberg

Commentary

The Effects of the Affordable Care Act on the Practice of Psychiatry

April 15, 2013

Michael H. Ebert, Robert L. Findling, Alan J. Gelenberg, et al

Commentary

Paradigm Shift: Preliminary Clinical Categorization of Ultrahigh Risk for Childhood Bipolar Disorder to Facilitate Studies on Prevention

February 15, 2013

Robert M. Post, Kiki Chang, Mark A. Frye

Commentary

Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences

February 15, 2013

Elaine R. Peskind, David Brody, Ibolja Cernak, et al

Commentary

Caring for Returning Veterans: Meeting Mental Health Needs

January 15, 2013

Terence M. Keane, Basit Chaudhry, John P. Docherty, et al

Commentary

Methodologies to Avoid the Enrollment of Ineligible Patients in Clinical Trials

November 15, 2012

Mauricio Tohen

Commentary

Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management

October 25, 2012

Learn about making an accurate diagnosis of MS, why early recognition is critical, and what treatments are most effective.

Emmanuelle Waubant

Commentary

Monitoring Clozapine Adverse Effects Calls for the Integration of Protocol and Good Clinical Practice

October 15, 2012

M. Bak

Commentary

Changes in the Product Label for Pimozide Illustrate Both the Promises and the Challenges of Personalized Medicine

September 15, 2012

Sheldon H. Preskorn

Commentary

"Bath Salts" and the Return of Serotonin Syndrome

August 15, 2012

J. J. Rasimas

Commentary

Can We Incorporate Psychosocial Treatment Interventions Into Psychopharmacology Clinical Trials?

July 15, 2012

Nina R. Schooler

Commentary

Would Broadening the Diagnostic Criteria for Bipolar Disorder Do More Harm Than Good? Implications From Longitudinal Studies of Subthreshold Conditions

April 15, 2012

Mark Zimmerman

Commentary

Lowering the Diagnostic Threshold for Bipolar Disorder: The Wrong Stuff?

April 15, 2012

Joseph F. Goldberg

Commentary

Benzodiazepines, Posttraumatic Stress Disorder, and Veterans: Good News and Why We' re Not Done Yet

March 15, 2012

Bruce P. Capehart

Commentary

Emerging Bias in the Treatment of Posttraumatic Stress Disorder

March 15, 2012

David C. Emelity

« 1 … 9 10 11 12 13 14 »

Commentary

Efficacy of Varenicline for Smoking Cessation in Bipolar Disorder

Update on Best Practices for Managing Bipolar Depression

Schizophrenia: Mechanism of Action of Current and Novel Treatments

Schizophrenia: The Role of Dopamine and Glutamate

Depression and Risk of Dementia: Exploring the Interface

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

Preventing Domestic Violence in Families of Veterans

Commentary: Psychiatric Pharmacist Integration Into the Medical Home

The Law of Diminishing Intent: Getting Excited About Apathy

The Effects of the Affordable Care Act on the Practice of Psychiatry

Paradigm Shift: Preliminary Clinical Categorization of Ultrahigh Risk for Childhood Bipolar Disorder to Facilitate Studies on Prevention

Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences

Caring for Returning Veterans: Meeting Mental Health Needs

Methodologies to Avoid the Enrollment of Ineligible Patients in Clinical Trials

Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management

Monitoring Clozapine Adverse Effects Calls for the Integration of Protocol and Good Clinical Practice

Changes in the Product Label for Pimozide Illustrate Both the Promises and the Challenges of Personalized Medicine

"Bath Salts" and the Return of Serotonin Syndrome

Can We Incorporate Psychosocial Treatment Interventions Into Psychopharmacology Clinical Trials?

Would Broadening the Diagnostic Criteria for Bipolar Disorder Do More Harm Than Good? Implications From Longitudinal Studies of Subthreshold Conditions

Lowering the Diagnostic Threshold for Bipolar Disorder: The Wrong Stuff?

Benzodiazepines, Posttraumatic Stress Disorder, and Veterans: Good News and Why We' re Not Done Yet

Emerging Bias in the Treatment of Posttraumatic Stress Disorder

ELSEWHERE:

FOLLOW US:

Commentary

Efficacy of Varenicline for Smoking Cessation in Bipolar Disorder

Update on Best Practices for Managing Bipolar Depression

Schizophrenia: Mechanism of Action of Current and Novel Treatments

Schizophrenia: The Role of Dopamine and Glutamate

Depression and Risk of Dementia: Exploring the Interface

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

The Pervasive and Persistent Neurobiological and Clinical Aftermath of Child Abuse and Neglect

Preventing Domestic Violence in Families of Veterans

Commentary: Psychiatric Pharmacist Integration Into the Medical Home

The Law of Diminishing Intent: Getting Excited About Apathy

The Effects of the Affordable Care Act on the Practice of Psychiatry

Paradigm Shift: Preliminary Clinical Categorization of Ultrahigh Risk for Childhood Bipolar Disorder to Facilitate Studies on Prevention

Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences

Caring for Returning Veterans: Meeting Mental Health Needs

Methodologies to Avoid the Enrollment of Ineligible Patients in Clinical Trials

Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management

Monitoring Clozapine Adverse Effects Calls for the Integration of Protocol and Good Clinical Practice

Changes in the Product Label for Pimozide Illustrate Both the Promises and the Challenges of Personalized Medicine

"Bath Salts" and the Return of Serotonin Syndrome

Can We Incorporate Psychosocial Treatment Interventions Into Psychopharmacology Clinical Trials?

Would Broadening the Diagnostic Criteria for Bipolar Disorder Do More Harm Than Good? Implications From Longitudinal Studies of Subthreshold Conditions

Lowering the Diagnostic Threshold for Bipolar Disorder: The Wrong Stuff?

Benzodiazepines, Posttraumatic Stress Disorder, and Veterans: Good News and Why We' re Not Done Yet

Emerging Bias in the Treatment of Posttraumatic Stress Disorder

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles